Anti-PD-1 Checkpoint Inhibitors
Immune checkpoint inhibitors that block the PD-1 receptor on T cells, restoring anti-tumor immune response. Used across many solid-tumor cancers including melanoma, NSCLC, and renal cell carcinoma.
Immune checkpoint inhibitors that block the PD-1 receptor on T cells, restoring anti-tumor immune response. Used across many solid-tumor cancers including melanoma, NSCLC, and renal cell carcinoma.